An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 4, 2003-03 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer’s Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 2-3, 2012-05 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

Do Lesions Involving the Cortical Cholinergic Pathways Help or Hinder Efficacy of Donepezil in Patients with Alzheimer’s Disease?

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 421-431

Karger

Access to resources Recommend Favorite

Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 5, 2009-11 ,pp. : 478-492

Karger

Access to resources Recommend Favorite